title: Bilateral lacrimal gland enlargement due to post-transplant lymphoproliferative disorder.
authors.forename: D
authors.initials: D
authors.lastname: Cheung
authors.forename: V
authors.initials: V
authors.lastname: Prabhakaran
authors.forename: L
authors.initials: L
authors.lastname: Brown
authors.forename: R N M
authors.initials: RN
authors.lastname: Stitson
authors.forename: R
authors.initials: R
authors.lastname: Sampath
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D016572:Cyclosporine / Q000009:adverse effects; D020031:Epstein-Barr Virus Infections; D006801:Humans; D007150:Immunohistochemistry; D007155:Immunologic Factors / Q000627:therapeutic use*; D016030:Kidney Transplantation; D007766:Lacrimal Apparatus Diseases / Q000473:pathology / Q000821:virology*; D008232:Lymphoproliferative Disorders / Q000473:pathology / Q000821:virology*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab; D016572:Cyclosporine